Analysis of information sources in references of the Wikipedia article "שימוש לא נכון באנטיביוטיקה" in Hebrew language version.
{{cite web}}: (עזרה)From 1995 to 2002, inappropriate antibiotic prescribing for acute respiratory infections, which are usually caused by viruses and thus are not responsive to antibiotics, declined from 61% to 49%. However, the use of broad-spectrum antibiotics such as the fluoroquinolones, jumped from 41% to 77% from 1995 to 2001. Overuse of these antibiotics will eventually render them useless for treating antibiotic-resistant infections, for which broad-spectrum antibiotics are supposed to be reserved.
{{cite web}}: (עזרה){{cite web}}: (עזרה)Gatifloxacin and moxifloxacin have no proven clinical advantages over other fluoroquinolones, macrolides, or amoxicillin. Based on cost, they are not first-choice drugs for their approved indications.
{{cite web}}: (עזרה){{citation}}: (עזרה), which cites{{citation}}: (עזרה), which cites{{citation}}: (עזרה), which cites{{citation}}: (עזרה){{citation}}: (עזרה), which cites{{citation}}: (עזרה)תחזוקה - ציטוט: multiple names: authors list (link){{cite web}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite journal}}: (עזרה){{cite web}}: תחזוקה - ציטוט: multiple names: authors list (link){{cite journal}}: (עזרה){{cite web}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה)From 1995 to 2002, inappropriate antibiotic prescribing for acute respiratory infections, which are usually caused by viruses and thus are not responsive to antibiotics, declined from 61% to 49%. However, the use of broad-spectrum antibiotics such as the fluoroquinolones, jumped from 41% to 77% from 1995 to 2001. Overuse of these antibiotics will eventually render them useless for treating antibiotic-resistant infections, for which broad-spectrum antibiotics are supposed to be reserved.
{{cite web}}: (עזרה)Gatifloxacin and moxifloxacin have no proven clinical advantages over other fluoroquinolones, macrolides, or amoxicillin. Based on cost, they are not first-choice drugs for their approved indications.
{{cite web}}: (עזרה)